The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Treatment of acute pulmonary embolism using the AngioJet rheolytic thrombectomy system

DOI: 10.4244/EIJ-D-20-00259

1. Department of Vascular and Endovascular Surgery, Henan Provincial People’s Hospital; People’s Hospital of Zhengzhou University; People’s Hospital of Henan University, Zhengzhou, Henan, 450003, China
2. Department of Vascular and Endovascular Surgery, Henan Provincial People's Hospital; People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, China, China

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please log in to download the PDF.

Aims: This retrospective study aimed to evaluate the therapeutic effects of AngioJet rheolytic thrombectomy system (ART) in treating severe acute pulmonary embolism (APE), including high-risk pulmonary embolism (HR-PE) and intermediate-high-risk pulmonary embolism (IHR-PE).

Methods and Results: Forty-four APE patients (21 HR-PE and 23 IHR-PE) were enrolled and underwent pulmonary ART using 6-French Solent Omini AngioJet device. Nineteen patients were diagnosed with APE and lower extremity deep venous thrombosis (LEDVT), and underwent thrombectomy of APE and LEDVT simultaneously using ART. All patients also received local thrombolysis with urokinase. The results showed that the mean length of stay in intensive care units was 2.4 ± 1.9 days. The significant improvement in clinical, hemodynamic and angiographic parameters were observed in both groups, and the improvements in shock index, PaO2, and angiographic parameters were improved more obviously in the IHR-PE group. Six of 44 patients died in-hospital. During the follow-up, 35 of 38 patients were functioning well and no recurrence of APE was observed.

Conclusions: Pulmonary ART plus local thrombolysis of the pulmonary artery for HR-PE or IHR-PE is feasible and appears to be safe. Further studies are warranted to investigate comparative efficacy compared to existing treatments.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Plaque characteristics, high bleeding risk, a new transcatheter valve, disproportionate functional mitral regurgitation, interventions for heart failure, and more